Protalix BioTherapeutics
PLX
#8235
Rank
S$0.31 B
Marketcap
S$3.90
Share price
-2.38%
Change (1 day)
16.03%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): S$9.9 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are S$61.84 Million. In 2024 the company made an earning of S$6.6 Million a decrease over its 2023 earnings that were of S$14.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$9.9 M49.88%
2024 S$6.6 M-55.62%
2023 S$14.88 M-199.05%
2022 -S$15.04 Million-40.38%
2021 -S$25.22 Million-732.31%
2020 S$3.98 M-130.53%
2019 -S$13.07 Million189.85%
2018 -S$4.51 Million-95.29%
2017 -S$95.71 Million308.12%
2016 -S$23.45 Million-32.37%
2015 -S$34.68 Million10.11%
2014 -S$31.49 Million-7.59%
2013 -S$34.08 Million
2011 -S$39.46 Million-19.39%
2010 -S$48.96 Million20.87%
2009 -S$40.5 Million32.26%
2008 -S$30.62 Million-5.46%
2007 -S$32.39 Million
2004 -S$0.21 Million12.35%
2003 -S$0.19 Million-11.1%
2002 -S$0.22 Million-57.03%
2001 -S$0.49 Million1.03%
2000 -S$0.49 Million-53.22%
1999 -S$1.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.01 B 158,795.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.73 B 7,718.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$6.31 M-33.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.72 B 28,751.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel